About CV Ingenuity
CV Ingenuity is a Healthcare company based in Fremont (United States) founded in 2008, and was acquired by Covidien in December 2012. Paclitaxel-coated balloons for peripheral artery disease were developed. CV Ingenuity has raised $32.69 million across 5 funding rounds from investors including Western Technology Investment, Covidien and NEA. The company was acqui-hired. Its focus areas include Life Sciences, Cardiac and Vascular Disorders, Medical Devices and Therapeutic Devices. Its legal entity is CV Ingenuity Corp. Its competitors include Avinger, Pathway Medical Technologies and Intact Vascular; 3 of its 3 listed competitors have raised funding.
Company details
CV Ingenuity was established in 2008 in Fremont, United States, within the medical device sector. Focus was placed on creating a paclitaxel-coated drug-eluting balloon to address peripheral artery disease. Vascular obstructions were targeted for removal, while re-stenosis was inhibited using a tunable rapid release system. The company was acquired by Covidien, now integrated into Medtronic, in 2012.
- Headquarters Fremont, United States
- Stage Acquired
- SectorsHealthcare
- Website cvingenuity.com
- Social LinkedIn
- Acquired by Covidien (Dec 2012)
- Legal Name Cv Ingenuity Corp
- Total Equity Funding$32.69M (USD)
in 5 rounds
- Latest Funding Round$3.79M (USD), Debt – Convertible
Jan 2013
- InvestorsWestern Technology Investment
& 4 more
- Acquired byCovidien
(Dec 2012)
Funding Insights of CV Ingenuity
CV Ingenuity has successfully raised a total of $32.69M across 5 strategic funding rounds. The most recent funding activity was a Debt – Convertible round of $3.79 million completed in January 2013. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $32.69M
- Total Rounds 5
- Last Round Debt – Convertible — $3.79M
- First Round $1.75M
(May 2009)
- Investors Count 4
All 5 funding rounds of CV Ingenuity with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan 2013 | $3.79M | Debt – Convertible | – | – | – |
| Nov 2012 | $11.14M | Series B | – | – | – |
| Oct 2011 | $16.01M | Series B | – | New Enterprise Associates | |
| Jan 2011 | $3.79M | Series A | – | – | – |
| May 2009 | $1.75M | Seed | – | – | – |
5 investors in total: 5 institutional.
Investors in CV Ingenuity
CV Ingenuity has secured backing from 5 investors, including venture fund investors. Prominent investors backing the company include Western Technology Investment, Covidien and NEA.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Venture capital investments are offered to startups by NEA. | nea.com | Menlo Park, United States | ||
Venture debt is provided globally across multiple sectors. | 1980 | westerntech.com | Portola Valley, United States | |
US seed and early-stage startups are funded by Synergy Ventures. | synergyventures.net | Menlo Park, United States | ||
| biostar.capital | ||||
Medical devices for minimally invasive therapies are provided globally. | 2007 | covidien.com | Dublin, Ireland |
Investor details for CV Ingenuity
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of CV Ingenuity
4 dated milestones of CV Ingenuity across 5 years, from founding to its latest funding, stage changes and deals.
- Founded CV Ingenuity is founded.
- Funding First funding round of $1.8M.
- Exit Acquired by Covidien.
- Funding Latest funding round, Debt – Convertible, of $3.8M.
Competitors of CV Ingenuity
CV Ingenuity has 3 listed competitors in our database, 3 of them funded. They include Avinger, Pathway Medical Technologies and Intact Vascular.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| avinger.com | 2007 | Redwood, United States | $170.85M | 80 | Provider of image-guided catheter-based products for peripheral artery disease | |
| pathwaymedical.com | 1998 | Kirkland, United States | $101.93M | 158 | Smart devices are provided to clear peripheral arterial blockages. | |
| intactvascular.com | 2011 | Wayne, United States | $123.4M | 64 | Implants for repairing arteries after angioplasty are developed. |
Detailed competitors of CV Ingenuity
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Cardiac and Vascular Disorders
3 companies that operate in the same segment as CV Ingenuity (Cardiac and Vascular Disorders) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Gene-editing therapies for coronary artery disease are developed. | 2018 | Cambridge, Massachusetts, United States | USD 215.5 M | 255 | ||
Cardiac monitoring devices and applications are provided for heart health. | 2010 | Mountain View, California, United States | USD 114.38 M | USD 6.18 M | 67 | |
Therapies for lowering low-density lipoprotein cholesterol levels are developed. | 1998 | Ann Arbor, Michigan, United States | USD 129.7 M | USD 332.31 M | 304 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Cv Ingenuity
Complete news archive for CV Ingenuity
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about CV Ingenuity
CV Ingenuity was founded in 2008 and raised its 1st funding round 1 year after it was founded.
CV Ingenuity is headquartered in Fremont, United States. It is registered at Fremont, California, United States.
CV Ingenuity is a funded company, having raised a total of $32.69M across 5 funding rounds to date. The company's 1st funding round was a Seed of $1.75M, raised on May 2009.
CV Ingenuity was established in 2008 in Fremont, United States, within the medical device sector. Focus was placed on creating a paclitaxel-coated drug-eluting balloon to address peripheral artery disease. Vascular obstructions were targeted for removal, while re-stenosis was inhibited using a tunable rapid release system. The company was acquired by Covidien, now integrated into Medtronic, in 2012.
CV Ingenuity's top competitors include Avinger, Intact Vascular and Pathway Medical Technologies.
CV Ingenuity has 5 investors. Key investors include Western Technology Investment, Covidien, NEA, Synergy Ventures, and BioStar Capital.
CV Ingenuity operates through Cv Ingenuity Corp.
Yes. CV Ingenuity was acquired by Covidien in December 2012.